1172 related articles for article (PubMed ID: 19801494)
1. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
2. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
[TBL] [Abstract][Full Text] [Related]
3. Type I Diabetic Akita Mouse Model is Characterized by Abnormal Cardiac Deformation During Early Stages of Diabetic Cardiomyopathy with Speckle-Tracking Based Strain Imaging.
Zhou Y; Xiao H; Wu J; Zha L; Zhou M; Li Q; Wang M; Shi S; Li Y; Lyu L; Wang Q; Tu X; Lu Q
Cell Physiol Biochem; 2018; 45(4):1541-1550. PubMed ID: 29482192
[TBL] [Abstract][Full Text] [Related]
4. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.
Francois AA; Obasanjo-Blackshire K; Clark JE; Boguslavskyi A; Holt MR; Parker PJ; Marber MS; Heads RJ
Cardiovasc Res; 2018 Jan; 114(1):138-157. PubMed ID: 29045568
[TBL] [Abstract][Full Text] [Related]
5. Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function.
Bakermans AJ; Geraedts TR; van Weeghel M; Denis S; João Ferraz M; Aerts JM; Aten J; Nicolay K; Houten SM; Prompers JJ
Circ Cardiovasc Imaging; 2011 Sep; 4(5):558-65. PubMed ID: 21737602
[TBL] [Abstract][Full Text] [Related]
6. Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice.
Schaeffer PJ; Desantiago J; Yang J; Flagg TP; Kovacs A; Weinheimer CJ; Courtois M; Leone TC; Nichols CG; Bers DM; Kelly DP
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1263-73. PubMed ID: 19700627
[TBL] [Abstract][Full Text] [Related]
7. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
8. Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy.
Røe ÅT; Aronsen JM; Skårdal K; Hamdani N; Linke WA; Danielsen HE; Sejersted OM; Sjaastad I; Louch WE
Cardiovasc Res; 2017 Aug; 113(10):1161-1172. PubMed ID: 28472418
[TBL] [Abstract][Full Text] [Related]
9. Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.
Flagg TP; Cazorla O; Remedi MS; Haim TE; Tones MA; Bahinski A; Numann RE; Kovacs A; Schaffer JE; Nichols CG; Nerbonne JM
Circ Res; 2009 Jan; 104(1):95-103. PubMed ID: 19023131
[TBL] [Abstract][Full Text] [Related]
10. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
[TBL] [Abstract][Full Text] [Related]
11. [Early decrease in diastolic function in young type I diabetic patients as an initial manifestation of diabetic cardiomyopathy].
Schannwell CM; Schoebel FC; Heggen S; Marx R; Perings C; Leschke M; Strauer BE
Z Kardiol; 1999 May; 88(5):338-46. PubMed ID: 10413856
[TBL] [Abstract][Full Text] [Related]
12. Chronic cardiac structural damage, diastolic and systolic dysfunction following acute myocardial injury due to bromine exposure in rats.
Masjoan Juncos JX; Shakil S; Bradley WE; Wei CC; Zafar I; Powell P; Mariappan N; Louch WE; Ford DA; Ahmad A; Dell'Italia LJ; Ahmad S
Arch Toxicol; 2021 Jan; 95(1):179-193. PubMed ID: 32979061
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
14. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
15.
Zhang B; Novitskaya T; Wheeler DG; Xu Z; Chepurko E; Huttinger R; He H; Varadharaj S; Zweier JL; Song Y; Xu M; Harrell FE; Su YR; Absi T; Kohr MJ; Ziolo MT; Roden DM; Shaffer CM; Galindo CL; Wells QS; Gumina RJ
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209764
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents.
Wichi R; Malfitano C; Rosa K; De Souza SB; Salemi V; Mostarda C; De Angelis K; Irigoyen MC
Cardiovasc Diabetol; 2007 Apr; 6():14. PubMed ID: 17462095
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy.
Trost SU; Belke DD; Bluhm WF; Meyer M; Swanson E; Dillmann WH
Diabetes; 2002 Apr; 51(4):1166-71. PubMed ID: 11916940
[TBL] [Abstract][Full Text] [Related]
18. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
[TBL] [Abstract][Full Text] [Related]
19. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients.
Raev DC
Diabetes Care; 1994 Jul; 17(7):633-9. PubMed ID: 7924771
[TBL] [Abstract][Full Text] [Related]
20. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction.
Sena S; Hu P; Zhang D; Wang X; Wayment B; Olsen C; Avelar E; Abel ED; Litwin SE
J Mol Cell Cardiol; 2009 Jun; 46(6):910-8. PubMed ID: 19249310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
